Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -3,768 | -2,649 | N/A | N/A |
| Depreciation Amortization | N/A | 255 | 249 | N/A | N/A |
| Other Working Capital | N/A | 107 | -158 | N/A | N/A |
| Other Operating Activity | 0 | 0 | 159 | 0 | 0 |
| Operating Cash Flow | $N/A | $-3,406 | $-2,399 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -27 | N/A | N/A |
| Other Investing Activity | 0 | -12,352 | 248 | 0 | 0 |
| Investing Cash Flow | $N/A | $-12,352 | $221 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 24,866 | 24,755 | 0 | 0 |
| Financing Cash Flow | $N/A | $24,866 | $24,755 | $N/A | $N/A |
| Beginning Cash Position | N/A | 2,126 | 2,126 | N/A | N/A |
| End Cash Position | N/A | 11,234 | 24,703 | N/A | N/A |
| Net Cash Flow | $N/A | $9,108 | $22,577 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -3,406 | -2,399 | N/A | N/A |
| Free Cash Flow | 0 | -3,406 | -2,399 | 0 | 0 |